LFVNLFVNConsumer Defensive · Packaged Foods

LFVN Stock Forecast: LifeVantage Corp. Price Predictions for 2026-2027

Last close, 16 Nov 2026
$4.77
−4.02% on the day

The 2 Wall Street analysts covering LifeVantage Corp. hold a median 12-month price target of $6.5 — +36.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 82 of 100 as at 14 Nov 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$63.0M
Ticker Nerd rank
82/ 100
Median analyst target
$6.50
Analysts covering
2
Revenue$42.4M−23.1% y/y
Operating income$1.7M
Net income$1.3M
Free cash flow$3.7M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−9.8%
1M
−20.5%
YTD
−20.5%
1Y
−25.5%
From 52W high
−55.1%
From 52W low
+20.7%
$4
$11
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

LFVN stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores LifeVantage Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 14 Nov 2026
82/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Value
100
Accruals
98
Issuance
93
Quality
91
Volatility
82
Size
77
Revisions
29
Growth
22
Momentum
17

Value (100): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.

Momentum (17): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

LFVN stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on LFVN, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$4$5$6$7$8$9$10Jan 26Apr 26Jul 26Oct 26LFVNHigh $8.00Median $6.50Low $5.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says2 analysts
1 Buy1 Hold0 Sell
Low $5.00Median $6.50High $8.00

The green dot is the last close — the median target sits +36.3% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
13 Nov 2026Freedom BrokerMaintainsBuy$9.00 → $8.00
28 Aug 2026Lake StreetMaintainsHold$5.00 → $6.00
7 May 2026Lake StreetDowngradeHold$5.00
7 May 2026Lake StreetDowngradeHold—
18 Feb 2026Freedom BrokerMaintainsBuy—
14 Nov 2025Freedom BrokerMaintainsBuy—
14 Jan 2025Craig-HallumInitiatesBuy—
19 Dec 2024Lake StreetInitiatesBuy—
12 Feb 2014Imperial CapitalInitiatesIn-Line—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

LFVN appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

LFVN vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 16 Nov 2026, LifeVantage Corp. returned −25.5% against +11.3% for the S&P 500, dividends included.

LFVN vs S&P 500, last 12 monthsTotal return, rebased to 100
6080100120140160Jan 26Apr 26Jul 26Oct 26LFVNS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

LFVN analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
EPS revision, 90 days
−29.2%
Analysts raising
1
Analysts cutting
2
Fundamentals

LifeVantage Corp. (LFVN) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
23.7×

Cheaper than 32% of US stocks

Price / sales
0.4×

Cheaper than 85% of US stocks

Price / book
1.9×

Cheaper than 44% of US stocks

EV / EBITDA
8.2×

Cheaper than 44% of US stocks

Growth & margins
Revenue growth (YoY)
−22.0%

Higher than 11% of US stocks

Earnings growth (YoY)
−23.1%

Higher than 20% of US stocks

Gross margin
78.0%

Higher than 89% of US stocks

Operating margin
2.5%

Higher than 50% of US stocks

Net margin
1.6%

Higher than 50% of US stocks

Returns & dividend
Return on equity
8.2%

Higher than 58% of US stocks

Return on assets
4.4%

Higher than 73% of US stocks

Dividend yield
4.0%

Higher than 91% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

LifeVantage Corp. (LFVN) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • LifeVantage Corp. has a market value of $63.0M and an enterprise value of $58.7M.

  • Revenue in the twelve months to 30 June 2026: $182.6M. The latest quarter shrank 22.0% year on year.

  • Net income over the same four quarters: $5.1M, a 2.8% net margin.

  • Diluted earnings per share, trailing twelve months: $0.40.

  • Free cash flow in the twelve months to 30 June 2026: $6.7M.

  • LifeVantage Corp. spent $5.7M on share buybacks and $2.3M on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 12.5M.

  • Trailing P/E: 23.7×; forward P/E: 33.1× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 4.02%, paying out 90% of earnings.

  • LifeVantage Corp. employs 209 people — $874K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 15 Nov 2026

Data provided by Twelve Data

Peers

LFVN vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelPackaged Foods
CompanyMarket capTKN rank
LFVNLifeVantage Corp.$63.0M82
CLNNClene, Inc.$55.7M37
BRIDBridgford Foods Corp.$49.0M30
FTLFFitLife Brands, Inc.$79.6M40
BYNDBeyond Meat, Inc.$98.4M34
BOFBranchOut Food, Inc.$39.0M25
BHSTBioHarvest Sciences, Inc.$34.1M33

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own LifeVantage Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest LFVN news & analysis

LifeVantage Corporation (LFVN) Q1 2027 Earnings Call Transcript

Seeking Alpha · 10 Nov 2026neutral

The provided text identifies a Seeking Alpha transcript of LifeVantage Corporation’s Q1 2027 earnings call but includes no details from the call.

Why it matters — LFVN watchers can note that a quarterly earnings-call transcript is the news item, though the excerpt gives no company performance or outlook information.

Lifevantage (LFVN) Surpasses Q1 Earnings Estimates

Zacks Investment Research · 10 Nov 2026positive

LifeVantage reported quarterly earnings of $0.05 per share, above the Zacks Consensus Estimate of $0.03. Earnings were $0.18 per share in the year-ago quarter.

Why it matters — LFVN watchers may note that quarterly earnings exceeded the consensus estimate while declining from a year earlier.

What Lifevantage (LFVN) Said on Its Q1 Earnings Call

MarketBeat · 9 Nov 2026negative

LifeVantage reported a 22% revenue decline in its fiscal first quarter and outlined plans to overhaul its brand, digital sales tools and cost structure as it works to stabilize the business.

Why it matters — The update highlights the company’s revenue decline and the operational changes it is pursuing to stabilize the business.

LifeVantage Declares Quarterly Dividend

GlobeNewsWire · 9 Nov 2026positive

LifeVantage’s board approved a quarterly cash dividend of $0.050 per share. It will be paid on December 15, 2026, to stockholders of record at the close of business on December 1, 2026.

Why it matters — LFVN watchers may note the declared dividend amount and the payment and record dates.

LifeVantage Announces Financial Results for the First Quarter Fiscal 2027

GlobeNewsWire · 9 Nov 2026negative

LifeVantage reported first-quarter fiscal 2027 revenue of $37.1 million, down 22.0% year over year, and a net loss per diluted share of $0.02, compared with net income of $0.17 a year earlier. Adjusted earnings per diluted share were $0.05 and adjusted EBITDA was $1.9 million, both lower than a year ago.

Why it matters — The results show lower revenue across both reported regions and declines in adjusted earnings and adjusted EBITDA compared with the prior-year quarter.

FAQ

Frequently asked questions about LFVN stock

What is the LFVN stock price forecast for 2026-2027?

The 2 Wall Street analysts covering LifeVantage Corp. have a median 12-month price target of $6.5, with estimates ranging from $5 to $8. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is LFVN stock a buy right now?

Of the 2 analysts covering LifeVantage Corp., 1 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks LifeVantage Corp. 82 out of 100 across roughly 4,600 US stocks as at 14 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank LFVN?

As at 14 Nov 2026, LifeVantage Corp. ranks 82 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (100 of 100).

Will LFVN stock go up?

No one can know that. What the data says: the median 12-month target from 2 analysts implies +36.3% from the last close, and Ticker Nerd's factor model ranks LifeVantage Corp. 82 out of 100 as at 14 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the LFVN stock forecast for 2030?

No analyst covering LifeVantage Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for LFVN are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $5 to $8 over the next 12 months.

How has LFVN stock performed over the past year?

LifeVantage Corp. returned -25.5% over the 12 months to 16 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does LifeVantage Corp. do?

LifeVantage Corporation is a health and wellness company that develops and sells nutrigenomic activators, dietary supplements, nootropics, weight management products, and skin and hair care items. Its product portfolio includes Protandim, TrueScience, PhysIQ, Axio, and Petandim, which are marketed to support cellular health, personal care, energy, and wellness routines.

What is the latest news on LFVN?

The most recent item we track (Seeking Alpha, 10 Nov 2026): "LifeVantage Corporation (LFVN) Q1 2027 Earnings Call Transcript". The provided text identifies a Seeking Alpha transcript of LifeVantage Corporation’s Q1 2027 earnings call but includes no details from the call.

Company

About LifeVantage Corp.

LifeVantage Corporation is a health and wellness company that develops and sells nutrigenomic activators, dietary supplements, nootropics, weight management products, and skin and hair care items. Its product portfolio includes Protandim, TrueScience, PhysIQ, Axio, and Petandim, which are marketed to support cellular health, personal care, energy, and wellness routines. The company serves customers through a direct-selling model and operates across international markets in the Americas, Asia-Pacific, and Europe. LifeVantage Corporation focuses on science-based consumer health products that combine nutrition, beauty, and wellness, giving it a distinct position in the global nutritional supplements and personal care market.

CEO Mr. Terrence O. Moorehead · 209 employees · United States · https://www.lifevantage.com